Physics Procedia copyright form by 3pWS7hv

VIEWS: 5 PAGES: 3

									Our reference:                                                                                                                 Version Number: 1/2009
                                                                   ELSEVIER B.V.
                                                              PUBLISHING AGREEMENT

PLEASE PROVIDE US WITH THE FOLLOWING INFORMATION, REVIEW OUR POLICIES AND THE PUBLISHING
AGREEMENT AND INDICATE YOUR ACCEPTANCE OF THE TERMS
Article entitled:

Corresponding author:

To be published in The Procedia: Physics Procedia

I hereby assign to ELSEVIER B.V. the copyright in the manuscript identified above and any supplemental tables, illustrations or other
information submitted therewith that are intended for publication as part of or as a supplement to the manuscript (the “Article”) in all forms
and media (whether now known or hereafter developed), throughout the world, in all languages, for the full term of copyright, effective
when and if the article is accepted for publication. This transfer includes the right to provide the Article in electronic and online forms and
systems. No revisions, additional terms or addenda to this Agreement can be accepted without our express written consent. Authors at
institutions that place restrictions on copyright assignments, including those that do so due to policies about local institutional repositories,
are encouraged to obtain a waiver from those institutions so that the author can accept our publishing agreement.

I confirm that I have read and understand the full list of rights retained by authors and also agree to the other General Terms of Publication
(see below).

YOUR STATUS
      I am the sole author of the manuscript
      Please indicate if any of the below also apply to you:
         I am a UK Government employee electing to transfer copyright
         I am a UK, Canadian or Australian Government employee and Crown Copyright is claimed
         I am a US Government employee and there is no copyright to transfer
         I am a contractor of the US Government under contract number: ……………………………………….……………………….

          I am one author signing on behalf of all co-authors of the manuscript
          Please indicate if any of the below also apply to you and your co-authors:
             We are all US Government employees and there is no copyright to transfer
             I am a US Government employee but some of my co-authors are not
             I am not a US Government employee but some of my co-authors are
             The work was performed by contractors of the US Government under contract number:………………….…………..………...
             We are all UK Government employees electing to transfer copyright
              We are all UK, Canadian or Australian Government employees and Crown Copyright is claimed
              I am not claiming Crown Copyright but some of my co-authors are employees of the UK, Canadian or Australian
          Government

          The article is a ‘work made for hire’ and I am signing as an authorized representative of my employer.
          Name and job title of assignee if different from Corresponding Author: .....................................................................................
          Please indicate if any of the below also apply to you:
             The article is authored by US Government employees and there is no copyright to transfer
                The work was performed by contractors of the US Government under contract number:
          ………………………………………..
             The article is authored by UK, Canadian or Australian Government employees and Crown Copyright is claimed

FUNDING
      No funding was received for the research reported in the article

          The research reported in the article was funded by the US National Institutes of Health

          The research reported in the article was funded by the Brazilian Government

          The research reported in the article was funded by other agencies
          For information on funding agencies and our arrangements with funding bodies in general please visit
          www.elsevier.com/fundingbodyagreements.


Please mark one or more of the above boxes (as appropriate) and then sign and date the document

Signed: ____________________________________                          Name printed: _________________________________

Title and Company (if employer representative) :_________________________________________________________

Date: ________________________________

How we use your information: Our staff at Elsevier B.V. and its affiliated companies worldwide will be contacting you concerning the
publishing of your article and occasionally for marketing purposes.

          Please tick the box if you do not wish to receive news, promotions and special offers about our products and services.
Our reference:                                                                                              Version Number: 1/2009
Please return the completed and signed original of this form by mail or fax, or by e-mailing a scanned copy of the signed original, retaining
a copy for your files, to:

<Guest editor>
<Organisation>
<institute>
<department>
<address>
<address-contd>
<city>
<postcode>
<country>
E-mail: <email>
Fax: <fax>
Our reference:                                                                                                 Version Number: 1/2009

General Terms of Publication

Retained Rights
I understand that I retain or am hereby granted (without the need to obtain further permission) rights to use certain versions of the Article
for certain scholarly purposes, as described and defined below (“Retained Rights”), and that no rights in patents, trademarks or other
intellectual property rights are transferred to the Procedia.

         the right to make copies (print or electric) of the article for own personal use, including for own classroom teaching use;
         the right to make copies and distribute copies (including via e-mail) of the article to research colleagues, for personal use by such
          colleagues (but not for Commercial Purposes, as listed below);
         the right to post a pre-print version of the article on Internet web sites including electronic pre-print servers, and to retain
          indefinitely such version on such servers or sites;
         the right to post the Accepted Author Manuscript (see Definitions) on the author's personal or institutional web site or server,
          incorporating the complete citation and with a link to the Digital Object Identifier (DOI) of the article;
         the right to present the article at a meeting or conference and to distribute copies of such paper or article to the delegates
          attending the meeting;
         for the author’s employer, if the article is a ‘work for hire’, made within the scope of the author’s employment, the right to use all
          or part of the information in (any version of) the article for other intra-company use (e.g. training), including by posting the
          article on secure, internal corporate intranets;
         the right to include the article, in full or in part, in a thesis or dissertation;
         the right to use the article or any part thereof in a printed compilation of works of the author, such as collected writings or lecture
          notes (subsequent to publication of the article in the Procedia); and
         the right to prepare other derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts
          in other works, with full acknowledgement of its original publication in the Procedia.

Author Representations/Ethics and Discolosure
I affirm the Author Representations noted below, and confirm that I have reviewed and complied with the relevant Instructions to Authors,
the Ethics in Publishing policy, and Conflicts of Interest disclosure. For further information see the publishing ethics page at
http://www.elsevier.com/wps/find/intro.cws_home/publishing and the Procedia home page.

Author representations
   The article I have submitted to the Procedia for review is original, has been written by the stated authors and has not been published
    elsewhere.
   The article is not currently being considered for publication by any other journal and will not be submitted for such review while
    under review by this Physics Procedia.
   The article contains no libellous or other unlawful statements and does not contain any materials that violate any personal or
    proprietary rights of any other person or entity.
   I have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have
    credited the sources in my article.
   If I am using any personal details or images of patients or research subjects, I have obtained written permission or consent from the
    patient (or, where applicable, the next of kin). See http://www.elsevier.com/patientphotographs for further information.
   If the article was prepared jointly with other authors, I have informed the co-author(s) of the terms of this publishing agreement and
    that I am signing on their behalf as their agent, and I am authorized to do so.

Funding agency requirements and other policies
I have also been made aware of the Procedia’s policies with respect to funding agency requirements such as the NIH ‘PublicAccess’
policy, and the rapid publication ‘ArticlesInPress’ service. See
http://www.elsevier.com/wps/find/authorsview.authors/fundingbodyagreements for details.

DEFINITIONS

Accepted Author Manuscript (“AAM”)
Author’s version of the manuscript of a paper that has been accepted for publication and which may include any author-incorporated
changes suggested through the peer review process. AAMs should not include however other publisher value added contributions such as
formatting and pagination.

Commercial Purposes
The use or posting of articles for commercial gain including the posting by companies or their employee-authored works for use by
customers of such companies (e.g. pharmaceutical companies and physician-prescribers); commercial exploitation such as directly
associating advertising with such postings; the charging of fees for document delivery or access; the systematic distribution to others via e-
mail lists or list servers (to parties other than known colleagues), whether for a fee or for free.

								
To top